Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cowealth Medical China CoSHSE:603122 -9.96%41 Days Payable is 180.71 as of Mar. 2026, which is 239% above its 10-year median of 53.35. GuruFocus rates SHSE:603122 with a GF Score™ of 41/100 and a GF Value™ of ¥3.85 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Cowealth Medical China Co ranks better than 79.47% on this metric.
The historical rank and industry rank for Cowealth Medical China Co's Days Payable or its related term are showing as below:
SHSE:603122'
s Days Payable Range Over the Past 10 Years
Min: 35.45 Med: 53.35 Max: 200.43
Current: 200.43
During the past 9 years, Cowealth Medical China Co's highest Days Payable was 200.43. The lowest was 35.45. And the median was 53.35.
SHSE:603122's Days Payable is ranked better than 79.47% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.64
vs SHSE:603122: 200.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603122 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Cowealth Medical China Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cowealth Medical China Co Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Cowealth Medical China Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Cowealth Medical China Co's Days Payable falls into.
Cowealth Medical China Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cowealth Medical China Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cowealth Medical China Co (SHSE:603122) has a Days Payable of 180.71 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cowealth Medical China Co and its competitors. This is 239% above median its historical median of 53.35. Over the past decade, Cowealth Medical China Co's Days Payable has ranged from 35.45 to 200.43. According to the industry distribution chart, Cowealth Medical China Co ranks #39 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 20.5%.
Is Cowealth Medical China Co's Days Payable too high?
Cowealth Medical China Co's current Days Payable of 180.71 is 239% above median its 10-year median of 53.35. Over the past 10 years, this metric has ranged from a low of 35.45 to a high of 200.43. The Medical Diagnostics & Research industry median Days Payable is 64.64. Cowealth Medical China Co's value of 180.71 is 179.6% above this industry median. Based on the distribution chart, Cowealth Medical China Co ranks #39 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Cowealth Medical China Co has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical China Co's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Cowealth Medical China Co ranks #39 out of 190 companies for Days Payable. This places Cowealth Medical China Co in the top 21% of its industry — outperforming the majority of peers. The industry median Days Payable is 64.64. Cowealth Medical China Co's value of 180.71 is 179.6% above this benchmark. Historically, Cowealth Medical China Co's own Days Payable has ranged from 35.45 to 200.43 over the past decade. While the company's 10-year median is 53.35 vs. the industry median of 64.64, Cowealth Medical China Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.64, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cowealth Medical China Co's current Days Payable of 180.71 is 179.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cowealth Medical China Co and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cowealth Medical China Co's current Days Payable is 180.71, which is 239% above median its own 10-year median of 53.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical China Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical China Co (SHSE:603122) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.85, compared to a current price of ¥10.31 — trading 167.8% above its estimated fair value. The current Days Payable is 180.71, which is 239% above median its 10-year median of 53.35 and 179.6% above the Medical Diagnostics & Research industry median of 64.64. Cowealth Medical China Co's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cowealth Medical China Co (SHSE:603122), the current Days Payable is 180.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cowealth Medical China Co (SHSE:603122) Overvalued in 2026?
Based on GuruFocus' analysis, Cowealth Medical China Co stock appears to be overvalued.
The current stock price of ¥10.31 is trading 167.8% above its estimated GF Value™ of ¥3.85.
GuruFocus considers Cowealth Medical China Co to be Significantly Overvalued.
Key valuation signals for SHSE:603122:
Days Payable: 180.71 (239% above median its 10-year median of 53.35)
GF Value™: ¥3.85 vs. price of ¥10.31 (167.8% above fair value)
Industry Position: 179.6% above the Medical Diagnostics & Research median (#39 of 190)
No single metric tells the full story. See the SHSE:603122 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603122 has been successfully added to your 
